Anti-inflammatory effects of seven years treatment with Omalizumab in severe uncontrolled asthmatics
Authors:
- E. PaceEPE. Pace
- M. FerraroMFM. Ferraro
- A. BrunoABA. Bruno
- J. BousquetJBJ. Bousquet
- M. GjomarkajMGM. Gjomarkaj
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- CREB/ATF-dependent T cell receptor–induced FoxP3 gene expression: a role for DNA methylationJournal of Experimental Medicine, 2007
- Variable p‐CREB expression depicts different asthma phenotypesAllergy, 2007
- Foxp3 Represses Retroviral Transcription by Targeting Both NF-κB and CREB PathwaysPLOS Pathogens, 2006
- Inflammatory events in severe acute asthmaAllergy, 2004
- Immunological and Clinical Changes in Allergic Asthmatics following Treatment with OmalizumabInternational Archives of Allergy and Immunology, 2003